Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Prodrug Approaches to Drug Delivery
by
Hu, Longqin
in
drug activation mechanism
/ drug delivery
/ drug release mechanism
/ intellectual property rights
/ pharmaceutical barriers
/ pharmacokinetic barriers
/ prodrug design
/ systemic bioavailability
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Prodrug Approaches to Drug Delivery
by
Hu, Longqin
in
drug activation mechanism
/ drug delivery
/ drug release mechanism
/ intellectual property rights
/ pharmaceutical barriers
/ pharmacokinetic barriers
/ prodrug design
/ systemic bioavailability
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Book Chapter
Prodrug Approaches to Drug Delivery
2016
Request Book From Autostore
and Choose the Collection Method
Overview
This chapter focuses on the various prodrug approaches that have been used to overcome many of the pharmaceutical and pharmacokinetic barriers that hinder the optimal delivery of the active drug. The most important requirement in prodrug design is naturally the adequate reconversion of the prodrug to the active drug in vivo at the intended compartment. This prodrug‐drug conversion may take place before absorption, in the GI system, during absorption such as in the GI wall or skin, after absorption, or at the specific site of drug action. A number of enzymes can also be delivered to targeted tissues through antibodies or gene delivery approaches for the activation of subsequently administered prodrugs. Although they are of limited use in small‐molecule pro‐drugs, Schiff bases have been used to conjugate amine‐containing drugs to polymers with carbonyl groups as macromolecular prodrugs for slow release and targeting.
Publisher
John Wiley & Sons, Inc
Subject
ISBN
1118833368, 9781118833360
This website uses cookies to ensure you get the best experience on our website.